Genomic assessments of the frequent loss of heterozygosity region on 8p21.3∼p22 in head and neck squamous cell carcinoma

Cancer Genetics and Cytogenetics

Volumn 176, Issue 2, 2007, Pages 100-106

  Ye, Hui ^a,b   Pungpravat, Nisa ^c   Huang, Bau Lin ^c   Muzio, Lorenzo L ^d   Mariggiò, Maria A ^e   Chen, Zugen ^f   Wong, David T ^c,f   Zhou, Xiaofeng ^a,g  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF FOGGIA   (Italy)

^e UNIVERSITY OF BARI   (Italy)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALLELE; ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CHROMOSOME 10P; CHROMOSOME 11Q; CHROMOSOME 17P; CHROMOSOME 3P; CHROMOSOME 4P; CHROMOSOME 4Q; CHROMOSOME 8P; CHROMOSOME 9P; CHROMOSOME ABERRATION; CONTROLLED STUDY; DOWN REGULATION; EXON; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENE LOCATION; GENETIC STABILITY; GENOME ANALYSIS; HEAD AND NECK CARCINOMA; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; MTUS1 GENE; NUCLEOTIDE SEQUENCE; POLYMORPHIC LOCUS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; BASE SEQUENCE; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CHROMOSOMES, HUMAN, PAIR 8; DNA MUTATIONAL ANALYSIS; GENE EXPRESSION PROFILING; GENE FREQUENCY; GTP-BINDING PROTEINS; HEAD AND NECK NEOPLASMS; HUMANS; LOSS OF HETEROZYGOSITY; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; TUMOR SUPPRESSOR PROTEINS;

EID: 34447558232     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2007.04.003     Document Type: Article

References (35)

1. Jemal A., Siegel R., Ward E., Murray T., Xu J., Smigal C., and Thun M.J. Cancer statistics, 2006. CA Cancer J Clin 56 (2006) 106-130
2. Parkin D.M., Bray F., Ferlay J., and Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 55 (2005) 74-108
3. Parkin D.M., Pisani P., and Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 80 (1999) 827-841
4. Lazarus P., and Park J.Y. Metabolizing enzyme genotype and risk for upper aerodigestive tract cancer. Oral Oncol 36 (2000) 421-431
5. Reichart P.A. Identification of risk groups for oral precancer and cancer and preventive measures. Clin Oral Investig 5 (2001) 207-213
6. Nagpal J.K., and Das B.R. Oral cancer: reviewing the present understanding of its molecular mechanism and exploring the future directions for its effective management. Oral Oncol 39 (2003) 213-221
7. Zhou X., Yu T., Cole S.W., and Wong D.T. Advancement in characterization of genomic alterations for improved diagnosis, treatment and prognostics in cancer. Expert Rev Mol Diagn 6 (2006) 39-50
8. Pekarsky Y., Palamarchuk A., Huebner K., and Croce C.M. FHIT as tumor suppressor: mechanisms and therapeutic opportunities. Cancer Biol Ther 1 (2002) 232-236
9. Zabarovsky E.R., Lerman M.I., and Minna J.D. Tumor suppressor genes on chromosome 3p involved in the pathogenesis of lung and other cancers. Oncogene 21 (2002) 6915-6935
10. Dong J.T. Chromosomal deletions and tumor suppressor genes in prostate cancer. Cancer Metastasis Rev 20 (2001) 173-193
11. Zhou X., Li C., Mok S.C., Chen Z., and Wong D.T.W. Whole genome loss of heterozygosity profiling on oral squamous cell carcinoma by high-density single nucleotide polymorphic allele (SNP) array. Cancer Genet Cytogenet 151 (2004) 82-84
12. Zhou X., Mok S.C., Chen Z., Li Y., and Wong D.T. Concurrent analysis of loss of heterozygosity (LOH) and copy number abnormality (CNA) for oral premalignancy progression using the Affymetrix 10K SNP mapping array. Hum Genet 115 (2004) 327-330
13. Zhou X., Rao N.P., Cole S.W., Mok S.C., Chen Z., and Wong D.T. Progress in concurrent analysis of loss of heterozygosity and comparative genomic hybridization utilizing high density single nucleotide polymorphism arrays. Cancer Genet Cytogenet 159 (2005) 53-57
14. Seibold S., Rudroff C., Weber M., Galle J., Wanner C., and Marx M. Identification of a new tumor suppressor gene located at chromosome 8p21.3-22. FASEB J 17 (2003) 1180-1182
15. Zhou X., Temam S., Oh M., Pungpravat N., Huang B.L., Mao L., and Wong D.T. Global expression-based classification of lymph node metastasis and extracapsular spread of oral tongue squamous cell carcinoma. Neoplasia 8 (2006) 925-932
16. Lee S., Bang S., Song K., and Lee I. Differential expression in normal-adenoma-carcinoma sequence suggests complex molecular carcinogenesis in colon. Oncol Rep 16 (2006) 747-754
17. Pils D., Horak P., Gleiss A., Sax C., Fabjani G., Moebus V.J., Zielinski C., Reinthaller A., Zeillinger R., and Krainer M. Five genes from chromosomal band 8p22 are significantly down-regulated in ovarian carcinoma: N33 and EFA6R have a potential impact on overall survival. Cancer 104 (2005) 2417-2429
18. Lieberfarb M.E., Lin M., Lechpammer M., Li C., Tanenbaum D.M., Febbo P.G., Wright R.L., Shim J., Kantoff P.W., Loda M., Meyerson M., and Sellers W.R. Genome-wide loss of heterozygosity analysis from laser capture microdissected prostate cancer using single nucleotide polymorphic allele (SNP) arrays and a novel bioinformatics platform dChipSNP. Cancer Res 63 (2003) 4781-4785
19. Lin M., Wei L.J., Sellers W.R., Lieberfarb M., Wong W.H., and Li C. dChipSNP: significance curve and clustering of SNP-array-based loss-of-heterozygosity data. Bioinformatics 20 (2004) 1233-1240
20. Newton M.A., Gould M.N., Reznikoff C.A., and Haag J.D. On the statistical analysis of allelic-loss data. Stat Med 17 (1998) 1425-1445
21. Eisen M.B., Spellman P.T., Brown P.O., and Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A 95 (1998) 14863-14868
22. -ΔΔCt method. Methods 25 (2001) 402-408
23. Di Benedetto M., Pineau P., Nouet S., Berhouet S., Seitz I., Louis S., Dejean A., Couraud P.O., Strosberg A.D., Stoppa-Lyonnet D., and Nahmias C. Mutation analysis of the 8p22 candidate tumor suppressor gene ATIP/MTUS1 in hepatocellular carcinoma. Mol Cell Endocrinol 252 (2006) 207-215
24. Jin C., Jin Y., Wennerberg J., Annertz K., Enoksson J., and Mertens F. Cytogenetic abnormalities in 106 oral squamous cell carcinomas. Cancer Genet Cytogenet 164 (2006) 44-53
25. Wruck C.J., Funke-Kaiser H., Pufe T., Kusserow H., Menk M., Schefe J.H., Kruse M.L., Stoll M., and Unger T. Regulation of transport of the angiotensin AT2 receptor by a novel membrane-associated Golgi protein. Arterioscler Thromb Vasc Biol 25 (2005) 57-64
26. Nouet S., Amzallag N., Li J.M., Louis S., Seitz I., Cui T.X., Alleaume A.M., Di Benedetto M., Boden C., Masson M., Strosberg A.D., Horiuchi M., Couraud P.O., and Nahmias C. Trans-inactivation of receptor tyrosine kinases by novel angiotensin II AT2 receptor-interacting protein, ATIP. J Biol Chem 279 (2004) 28989-28997
27. Balczon R., Bao L., and Zimmer W.E. PCM-1, A 228-kD centrosome autoantigen with a distinct cell cycle distribution. J Cell Biol 124 (1994) 783-793
28. Corvi R., Berger N., Balczon R., and Romeo G. RET/PCM-1: a novel fusion gene in papillary thyroid carcinoma. Oncogene 19 (2000) 4236-4242
29. Reiter A., Walz C., Watmore A., Schoch C., Blau I., Schlegelberger B., Berger U., Telford N., Aruliah S., Yin J.A., Vanstraelen D., Barker H.F., Taylor P.C., O'Driscoll A., Benedetti F., Rudolph C., Kolb H.J., Hochhaus A., Hehlmann R., Chase A., and Cross N.C. The t(8;9)(p22;p24) is a recurrent abnormality in chronic and acute leukemia that fuses PCM1 to JAK2. Cancer Res 65 (2005) 2662-2667
30. Ishii H., Vecchione A., Murakumo Y., Baldassarre G., Numata S., Trapasso F., Alder H., Baffa R., and Croce C.M. FEZ1/LZTS1 gene at 8p22 suppresses cancer cell growth and regulates mitosis. Proc Natl Acad Sci U S A 98 (2001) 10374-10379
31. Hamaguchi M., Meth J.L., von Klitzing C., Wei W., Esposito D., Rodgers L., Walsh T., Welcsh P., King M.C., and Wigler M.H. DBC2, a candidate for a tumor suppressor gene involved in breast cancer. Proc Natl Acad Sci U S A 99 (2002) 13647-13652
32. Mittelstadt P.R., and Ashwell J.D. Cyclosporin A-sensitive transcription factor Egr-3 regulates Fas ligand expression. Mol Cell Biol 18 (1998) 3744-3751
33. Yasunaga J., Taniguchi Y., Nosaka K., Yoshida M., Satou Y., Sakai T., Mitsuya H., and Matsuoka M. Identification of aberrantly methylated genes in association with adult T-cell leukemia. Cancer Res 64 (2004) 6002-6009
34. Hymowitz S.G., Christinger H.W., Fuh G., Ultsch M., O'Connell M., Kelley R.F., Ashkenazi A., and de Vos A.M. Triggering cell death: the crystal structure of Apo2L/TRAIL in a complex with death receptor 5. Mol Cell 4 (1999) 563-571
35. Di Benedetto M., Bieche I., Deshayes F., Vacher S., Nouet S., Collura V., Seitz I., Louis S., Pineau P., Amsellem-Ouazana D., Couraud P.O., Strosberg A.D., Stoppa-Lyonnet D., Lidereau R., and Nahmias C. Structural organization and expression of human MTUS1, a candidate 8p22 tumor suppressor gene encoding a family of angiotensin II AT2 receptor-interacting proteins, ATIP. Gene 380 (2006) 127-136